| |
|
|
|
Vistagen Therap. Com  
|
|
0.49 0.065 (0.15%) |
05-28 16:00 |
|
Open: |
0.4351 |
Pre close: |
0.425 |
Target:
|
0.56 
|
|
High: |
0.5373 |
Low: |
0.43 |
Resistance:
|
0.48
0.56
|
|
Volume: |
3,331,508 |
Market Cap: |
24M |
Support:
|
0.35
0.29
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.41
|
MACD |
MACD(12,26):
|
-0.02  |
|
MA(20): |
0.43 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.59 |
Stochastic Oscillator |
%K(14,3):
|
21.05 |
|
MA(250): |
0.71 |
%D(3): |
23.39 |
|
Average Volume(K) |
3-Month: |
32582
|
52-Week |
High:
|
1.49 |
|
10-Days: |
28138 |
Low: |
0.29 |
|
RSI |
RSI(14):
|
43.32 |
Change(%): |
-64.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.900 |
Return on Equity (ttm) |
-2.1 |
Shares Out. (M) |
28.56 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-1.3 |
Shares Float (M) |
40.03 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.09 |
% Held by Insiders |
10.53 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.30 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1330 |
|
Book Value (p.s.) |
0.248 |
EBITDA (p.s.) |
-0.857 |
P/E |
-0.44 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.61 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.53 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-14.70 |
P/CF |
-0.79 |
|
|
|
|
|
|
